| |
Ms. Lynn Aneiro is the Director of Global Clinical Trial Operations, responsible for overseeing clinical trial processes including project management, clinical supply management, biostatistics, medical writing, study monitoring, medical monitoring, central laboratory coordination and pharmacovigilance. Prior to joining Clinilabs, Ms. Aneiro was the Senior Director of Clinical Operations for Neurogen Corporation, a biotechnology company with compounds in early clinical development. Prior to her work at Neurogen, Ms. Aneiro was an employee of the Bayer Corporation for several years, where she held progressively responsible positions managing clinical trials in Phases II - IV, including global trials, pediatric studies, and post marketing studies. She also worked in the areas of clinical project management, clinical site monitoring, personnel line management, and vendor management and has worked as a consultant in the field of clinical operations.
Lynn earned a BS in Biochemistry from Trinity College, an MHS in Medical Laboratory Sciences from Quinnipiac College and Professional Certification in Human Resource Management from the University of New Haven.
|
